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independent of reactive oxygen species (ROS), myeloperoxidase (MPO) or NE. 48
In vitro, NETs functioned to restrain parasite dissemination in a mechanism 49 dependent on MPO and NE activities. Finally, C57/B6 mice infected with P. 50 berghei ANKA, a well-established model of cerebral malaria, presented high 51 Introduction 74 Malaria is a highly prevalent and widespread infectious disease caused by 75 protozoans of the Plasmodium genus. Amongst the known agents of human 76 malaria, Plasmodium falciparum is associated with the complicated forms of 77 disease, including the potentially fatal cerebral malaria [1, 2] . Severe forms of 78 malaria infection can be associated with either impaired mechanisms of 79 resistance -and consequently high parasitemia [3,4] -or exacerbated tissue 80 damage due to ineffective mechanisms of disease tolerance [5] [6] [7] [8] . Studies on 81 the immunological mechanisms of tissue injury and host resistance to malarial 82 infection have generally focused on adaptive immune responses coordinated by 83 CD4+ T cells through the activation of CD8+ T and B cells [9] [10] [11] . However, 84 mounting evidences, from both human studies and the P. berghei ANKA murine 85 model of severe malaria, point to the involvement of other cell types, including 86 platelets, macrophages and neutrophils [12] [13] [14] [15] . 87
Neutrophils participate in the immune response to pathogens by using several 88 mechanisms of killing, including reactive oxygen species (ROS) production, 89 phagocytosis, and the release of antimicrobial peptides and cytotoxic enzymes 90 [16] . Neutrophils are capable of phagocytosing opsonized P. falciparum 91 merozoites [17] and P. falciparum-infected red blood cells [18] . Neutrophil ROS 92 production positively correlated with P. falciparum clearance and individuals 93 with higher ROS production presented faster parasite clearance time (PCT) 94
[19]. These observations would support a beneficial role of neutrophils in 95 mediating Plasmodium clearance and disease resistance in malaria. However, 96
in human malaria there is a strong correlation between neutrophil activation 97 markers and disease severity [14, 20, 21] , suggesting that overt neutrophil activation may contribute to disease pathogenesis. In fact, neutrophil depletion 99 resulted in decreased brain microhaemorrhages and monocyte sequestration, 100 preventing cerebral malaria development in mice [22, 23] . Therefore, whether 101 neutrophils are beneficial, contributing to pathogen clearance or detrimental, 102 inducing tissue damage during severe malaria remains unresolved. 103 Neutrophils can release DNA to the extracellular space, which has been shown 104 to function as traps for many different pathogens, including bacteria, fungi, 105 viruses and protozoans. These neutrophil extracellular traps (NET) evolved as a 106 unique innate immune defense mechanism capable of restraining pathogens, 107
avoiding their dissemination and contributing to pathogen killing [24]. However, 108
NETs have also the potential to harm surrounding heathy tissue, thus 109 contributing to both aspects of disease tolerance, i.e. pathogen elimination and 110 collateral tissue damage. It is therefore reasonable to hypothesize that 111 neutrophils and NETs may be involved in malaria pathogenesis. In fact, reports 112
show evidences of NET production in samples from human malaria patients [25, 113 26] . Moreover, it was recently shown that Plasmodium-infected red blood cells 114 are capable of triggering NET release [27] . NET disruption with DNAse 115 treatment resulted in milder lung injury and increased survival in a model of 116
Plasmodium-induced acute lung injury [27] . However, the mechanisms involved 117 in NET release in response to Plasmodium-infected erythrocytes remain 118
uncharacterized. 119
In the present study, we show that NETs are released by neutrophils exposed 120
to Plasmodium-infected erythrocytes and contribute to restrain pathogen spread 121 and control malaria infection. We also provide evidences that stimulation of NET 6 release is independent of cell-cell contact and is mediated by macrophage 123 migration inhibitory factor (MIF) activation of CXCR4. 124 production in response to infected erythrocytes is accompanied by cell death, 150
although it is difficult to ascertain whether LDH is derived from NETosing 151 neutrophils or rupturing erythrocytes. We further observed that NET induced by 152 P. falciparum-infected erythrocytes showed a cloud-like morphology ( Fig 1E) . 153
Although we detected a significant extracellular DNA signal using fluorimetric 154 assay as early as 15 minutes, NET-like structures only started to be detectable 155 by immunofluorescence at 60 minutes (data not shown) and peaked at 180 156 minutes ( Fig 1E) . NETs stained positively for NE and myeloperoxidase (MPO), 157 two characteristic enzymes found associated to DNA in NETs ( Fig 1E) . Finally, 158 these NET-like structures, as well as the fluorimetric signal were lost after 159
DNAse incubation ( Fig 1F and 1G ), suggesting that the structures we are 160 describing here meet the criteria to be classified as NETs. Altogether, these 161 results demonstrate that P. falciparum-infected erythrocytes stimulate human 162 neutrophils to release NETs in vitro. response to infected red blood cells is ROS-independent. Moreover, we 170 observed that uninfected erythrocytes were also able to induce ROS production 171 by human neutrophils, although to a smaller extent (S2C and S2D Figs). This 172 also argues against a possible involvement of ROS in NET release induced by 173 infected erythrocytes since we did not observe any NET production in response essential to NET production induced by different stimuli [28, 29] . We used two 176 well described inhibitors of MPO and NE to evaluate the involvement of these 177 two enzymes in NET production induced by P. falciparum-infected erythrocytes. 178
Neither inhibitor had any effects on NET production in this model, ruling out the 179 involvement of MPO and NE in this process (Figs 2B and 2C) . Cl-amidine, resulted in significant inhibition of NET production ( Fig 2E) , 185
suggesting the involvement of PAD4-induced histone citrullination in this 186 process. We treated neutrophils with different kinase inhibitors to define the 187 signaling pathways contributing to NET release in response to infected 188 erythrocytes. Incubation of human neutrophils with P. falciparum-infected red 189 blood cells induced increased PKCδ expression, in agreement with the 190 observed increased ROS production. We also observed increased immobilized immune complexes [33] . We incubated neutrophils with a CD18 203 blocking antibody during the interaction with infected erythrocytes. We found no 204 effects of anti-CD18, or the isotype control antibody, on NET release induced by 205 infected erythrocytes ( Fig 3A) . P. falciparum-infected erythrocytes interact with 206 endothelial cells through P. falciparum erythrocyte membrane protein 1 (PfEMP-207 1) expressed by infected erythrocytes. PfEMP-1 mediates cytoadhesion of 208 infected erythrocytes to endothelia through its interaction with CD36 and ICAM-209 1 expressed by endothelial cells [34, 35] . We reasoned that CD36 or ICAM-1 210 could have a role in mediating the recognition of infected erythrocytes and NET 211 production by human neutrophils. Incubation of neutrophils with an ICAM-1 212 blocking antibody did not interfere with NET production induced by infected 213 erythrocytes ( Fig 3B) . Similarly, incubation with an anti-CD36 blocking antibody 214 did not inhibit NET release ( Fig 3C) . These results show that neither of the 215 integrins known to be involved in NET production or erythrocyte cytoadherence, 216 nor CD36 are involved in the stimulation of NET release by infected 217 erythrocytes. We further treated neutrophils with cytochalasin D, a disruptor of 218 actin polymerization that inhibits phagocytosis. There are evidences of 219 neutrophil phagocytosis of infected red blood cells in human patients and also 220 there are evidences that phagocytosis may inhibit NET release [36] . However, 221 despite these evidences, NET release was neither increased nor decreased by 222 cytochalasin D ( Fig 3D) , ruling out the involvement of phagocytosis in this 223
process.
Recently it was demonstrated that aged neutrophils presenting increased 227 CXCR4 expression show enhanced capacity of NET release [37] . Moreover, a 228 report by Sercundes and cols. showed that NETs are involved in pulmonary 229 injury in a murine model of malaria and that CXCR4 inhibition protected mice 230 from acute lung injury [27] . We therefore used AMD3100, a CXCR4 antagonist, 231
to evaluate the involvement of CXCR4 in this model. We observed that 232 AMD3100 inhibited NET release induced by infected red blood cells ( Fig 4A) . 233 CXCL12 is the typical CXCR4 ligand, but this receptor can also be activated by 234 MIF, which functions as a non-cognate ligand [38] . Moreover, it has been 235 demonstrated that red blood cells are an important source of MIF, contributing 236 with ~99% of total MIF content in blood [39] . In fact, the cell-permeable MIF 237 antagonist, ISO 1, was able to inhibit NET release in response to infected 238 erythrocytes ( Fig 4B) . Additionally, treatment with an anti-MIF blocking antibody 239 resulted in a significant inhibition of NET release induced by infected 240 erythrocytes ( Fig 4C) . Finally, we could detect the presence of MIF in the 241 supernatant of infected, but not uninfected, erythrocytes ( Fig 4D) . Supernatant 242 derived from cultures of infected erythrocytes induced NET release by human 243 neutrophils ( Fig 4E) , an effect that could be blocked by anti-MIF antibody ( We then moved to a murine model of malaria, using P. berghei ANKA and bone 262 marrow-derived neutrophils from C57/BL6 mice. P. berghei ANKA is known to 263 induce a severe form of cerebral malaria in susceptible C57/BL6 mice and is 264 generally used as a model for the human form of P. falciparum-induced cerebral 265 malaria. Similarly to what we found in human neutrophils, incubation of mouse 266 neutrophils with P. berghei-infected red blood cells induced a significant 267 increase in extracellular DNA that was not observed in neutrophils incubated 268 with uninfected erythrocytes ( Fig 6A) . NET release by murine neutrophils was 269 also ROS-independent since it was unaffected by either DPI (Fig 6B) stained positively for MPO and citrullinated histones, but were slightly distinct from NETs released by human neutrophils in that it showed a fiber-like structure 274 ( Fig 6C) . Together, these results show that, similarly to what we described for 275 human neutrophils in response to P. falciparum-infected erythrocytes, murine 276 neutrophils release NET in response to P. berghei ANKA-infected erythrocytes, 277 in a process that is independent of ROS. 278
Finally, infection of C57/BL6 mice with P. berghei ANKA resulted in increased 279 plasmatic levels of circulating DNA ( Fig 6D) , which corroborates with our data 280 from S.M. patients ( Fig 1B) . P. berghei ANKA infection also resulted in sharp 281 mortality starting at day 7 and that reached a 40% survival rate by day 10 (Fig  282   6E ). Treatment of mice with DNAse (Pulmozyme) resulted in accelerated death, 283
with 20% survival at day 7 and 100% mortality by day 10 post-infection ( Fig 6E) . 284
Interestingly, this DNAse effect was paralleled by a significant increase in 285 parasitemia ( Fig 6F) , suggesting that NET functions to restrain parasite 286 dissemination in vivo in a similar fashion to what we observed in vitro. We observed that MIF, acting through CXCR4, were required to NET release 310 induced by infected red blood cells. Recent evidences suggest that red blood 311 cells are a major source of MIF in the bloodstream [39] . The mechanism by which MIF is released from infected erythrocytes is not well characterized. MIF 313 might be released after red cell lysis during the parasite cycle. However, unless 314 erythrocytes lyse immediately upon co-culture with neutrophils, only the 315 continuous release of MIF would explain NET being triggered as soon as 15 316 minutes. One possible alternative is that MIF could be released within red blood with clinical manifestations [26] . It is possible that overt neutrophil activation is 345 occurring in these patients, resulting in increased NET release but also 346 increased NET-independent tissue injury, i.e. by increased proteolytic activity, 347 cytokine release and/or increased oxidative stress. Therefore, attempts to target 348
NET or neutrophils in malaria should be taken with caution and consider the 349 complex interplay between both beneficial and detrimental roles played by 350 neutrophils in malaria. Malaria is the most frequent cause of admission in the pediatric service, 372
representing 44.9% of admissions, followed by acute respiratory infections 373 (26.4%) and diarrhea (11.2%) [45] . Malaria transmission is highly seasonal in 374 the study area. hospitalization cohort) and 42 participants with mild malaria (from the 378 longitudinal under-5 cohort, matched for age). Of the 23 severe malaria cases, 379 8 had cerebral malaria while the remaining had severe anemia or prostration. 380
Venous blood was drawn in EDTA tubes, and plasma was prepared by 381 centrifuging for 10 min at 1500g. Plasma was aliquoted and stored at -80°C. 382
ELISA. 383
ELISA kits used were Neutrophil Elastase (Abcam 119553, plasma dilution 384 1:500; standard range, 0.16-10 ng/ml) and Cell Death ELISA (Roche, 385 11774425001, plasma dilution 1:2) which estimates cytoplasmic histone-386 associated DNA fragments (mono-and oligonucleosomes, no standard range). 387
For the ordinal variables, differences between groups were calculated using the 388 non-parametric Mann-Whitney test. 389
Neutrophil purification. 390
Human neutrophils were isolated from peripheral blood using a histopaque 391 1077 density gradient as previously described [46] . Erythrocytes were lysed 392 with ACK solution and the pellet containing neutrophils was washed in HBSS 393 and ressuspended in cold RPMI 1640 medium. Isolated neutrophils were 394 routinely ≥ 95% pure and >99% viable. Murine neutrophils were isolated from 395 the bone marrow of C57/BL6 mice by percoll density gradient as described [47] . 
Mature trophozoites purification. 425
Mature trophozoites were isolated by percoll/sorbitol gradient as described 426
previously [49] . Briefly, cultures of infected erythrocytes with at least 5% 427 parasitemia were centrifuged at 900g for 15 min at room temperature. Pellet 428 was resuspended in fresh RPMI to reach a 20% hematocrit and gently poured 429 on top of a 40%, 70% and 90% Percoll/sorbitol gradient. After centrifugation the 430 brown band formed between the 40% and 70% layers was harvested and 431 suspensions of synchronized trophozoites (>90% of purity) were used to 432 stimulate neutrophils. 433
Fluorimetric quantification of NETs. 434
Neutrophils (2x10 5 cells) were stimulated with P. falciparum-infected 435 erythrocytes at varying neutrophil:erythrocyte ratios. After incubation, ECOR1 436 and HIINDIII restriction enzymes (20 units/mL each) were added and incubated 437 for 30 min at 37°C. Samples were then centrifuged and supernatants collected. 438 DNA concentration in the supernatants (referred to as NETs) was determined 439
using Picogreen dsDNA kit (Invitrogen) according to the manufacturer's 440 instructions. Uninfected erythrocytes from the same blood type were used as 441 control. 442
Visualization of NETs by immunofluorescence. 443
Neutrophils (2x10 5 ) were allowed to adhere onto 0.001% poly-L-lysine (Sigma) 444 coated glass coverslips. Neutrophil were then stimulated with 1x10 6 P. paraformaldehyde for 15 min at room temperature. After extensive wash in 447 PBS, unspecific binding sites were blocked with 3% BSA and cells were 448 incubated with primary anti-myeloperoxidase (1:1000, Abcam), anti-elastase 449
(1:1000, Abcam), or anti-citrullinated histone H3 (1:1000, Abcam) antibodies, 450 followed by the appropriate secondary fluorescent antibodies (1:4000). DNA 451 was counterstained with Hoesch. Images were acquired using a Leica confocal 452 microscope under 40X and 100X magnification. 453
Quantification of ROS production. 454
ROS production was measured using a fluorimetric assay based on the 455 oxidation of the CM-H2DCFDA probe (Molecular Probes) following the 456 manufacturer´s instructions. Briefly, 2x10 5 neutrophils and 10 6 infected 457 erythrocytes were mixed with 2 μM of CM-H2DCFDA probe in a 96 well plate. 458
Fluorescence was monitored every 10 min for 30 min. Uninfected erythrocytes 459
were used as controls. The same culture and stimulation procedure was carried 460 out for the visualization of ROS production under the microscope. Images were 461 acquired using a Leica DMI6000 fluorescence microscope under 20x 462 magnification after 1 hour of stimulation. 463
Parasite invasion and growth assays. 464
NET-rich supernatant was obtained from human neutrophils cultured with P. 465 falciparum-infected erythrocytes at a 1:10 ratio for 3 hours. Cultures were 466 centrifuged and NET-rich supernatant was collected for immediate use. 467
Supernatant obtained from neutrophils incubated with uninfected red blood cells 468 was used as control. Infected erythrocytes at 2% parasitemia were seeded in a 96-well plate in RPMI supplemented with 10% FCS to reach a 5% hematocrit. 470
NET-rich supernatants were added to the erythrocyte cultures which were 471 incubated at 37°C for 24 h. Parasite invasion was estimated by counting the 472 number of new intracellular ring forms in a thick blood smear stained with Diff-473
Quick. Invasion was expressed as the percentage of erythrocytes showing ring 474 forms of the parasite. Additionally, cultures were allowed to proceed for up to 48 475 h to analyze intracellular parasite growth. The number of infected erythrocytes, 476
including all parasite forms, was determined and expressed as the percentage 477 of infected red blood cells (iRBC). 478
Westernblot. 479
Whole-cell lysates were extracted by RIPA buffer and cleared by centrifugation 480 at 15000×g for 15 min at 4ºC prior to boiling in Laemmli buffer. Western blots 481 were performed using standard molecular biology techniques and membranes 482 were developed using Super Signal West Femto Maximum Sensitivity Substrate 483 (Thermo Scientific). Blot images were acquired in a ChemiDoc XRS system 484 (BioRad). Antibodies used were anti-p-JNK (Cell Signaling Technologies), anti-485 p-p38 (BD Biosciences), anti-p AKT (Cell Signaling Technologies), and anti-β-486 actin (Millipore). All primary antibodies were diluted 1:1000 in TBS-T. 487
In vivo assays. 488
All animal procedures were approved by the Institution Ethics Committee 489 (CEUA protocol number XXX). C57BL6 mice were treated intravenously with 490 either vehicle (0.9% NaCl sterile saline) or Pulmozyme (5 mg/kg, Roche) 1 hour 491 before infection. Pulmozyme treatment was continued every 8 hours for 6 days. 492 clinical signs of cerebral malaria and blood samples were collected daily for 494 parasitemia determination. 495
Statistical analysis. 496
Data are presented as means ± S.E.M. of at least 3 independent experiments. 497
All statistical analyses were performed using GraphPad Prism 6.0 for windows. 
